Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
Not Confirmed
Not Confirmed
30 September-02 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Industry Trade Show
Not Confirmed
30 September-02 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
30 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/en/news-release/2024/09/30/2955052/0/en/Akero-Therapeutics-to-Present-at-the-H-C-Wainwright-8th-Annual-MASH-Virtual-Conference.html
09 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/09/2942664/0/en/Akero-Therapeutics-Announces-First-Patient-Dosed-in-Phase-3-SYNCHRONY-Outcomes-Study-of-Efruxifermin-in-Patients-with-Compensated-Cirrhosis-Due-to-MASH.html
28 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/28/2937349/0/en/Akero-Therapeutics-to-Present-at-the-Morgan-Stanley-22nd-Annual-Global-Healthcare-Conference.html
09 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/09/2927685/0/en/Akero-Therapeutics-Reports-Second-Quarter-2024-Financial-Results-and-Provides-Business-Update.html
11 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/11/2896641/0/en/Akero-Therapeutics-Announces-Initiation-of-Phase-3-SYNCHRONY-Outcomes-Trial-of-Efruxifermin-in-Patients-with-Compensated-Cirrhosis-F4-Due-to-MASH.html
07 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/08/2895671/0/en/Akero-Therapeutics-Presents-Poster-and-Late-breaking-Oral-Presentation-on-EFX-at-the-EASL-Congress-2024.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?